To explore the underlying mechanism of leptin treatment on the inflammatory effect in AD mice, the p-AKT protein expression level in the hippocampus tissues, an important inflammatory response pathway, was evaluated by western blotting in the sham group, AD model group, and leptin + AD model group. Here, AKT1 is linked to Alzheimer disease.